Generation Bio Co. (GBIO)
Feb 9, 2026 - GBIO was delisted (reason: acquired by XOMA)
5.34
-0.40 (-6.97%)
Inactive · Last trade price on Feb 6, 2026

Generation Bio Co. Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-62.63-131.67-126.61-136.64-119.15-80.52
Depreciation & Amortization
4.854.935.265.134.533.43
Stock-Based Compensation
8.8414.6124.3424.4517.868.41
Other Adjustments
-4.1254.99-9.273.560.770.25
Change in Receivables
1.82-1.22-3.57-0.4-0.45
Changes in Accounts Payable
0.42-0.391.09-1.391.76-1.44
Changes in Accrued Expenses
4.77-7.964.290.81.833.43
Changes in Unearned Revenue
-12.01-15.1241.6---
Changes in Other Operating Activities
-37.13-6.7410.132.030.59-4.14
Operating Cash Flow
-113.65-88.56-52.75-102.45-91.82-70.14
Capital Expenditures
--2.4-7.4-8.8-5.96-5.52
Sale of Property, Plant & Equipment
0.520.2--0.11-
Purchases of Investments
-85.72-135.27-405.3-323.71--243.18
Proceeds from Sale of Investments
200232403140198.943.5
Investing Cash Flow
113.7294.53-9.7-192.52193.05-205.2
Issuance of Common Stock
-0.4436.551.26215.63217.47
Repurchase of Common Stock
-0.02-0.19-0.57-0.58--
Net Common Stock Issued (Repurchased)
-0.020.2535.980.68215.63217.47
Issuance of Preferred Stock
-----108.85
Net Preferred Stock Issued (Repurchased)
-----108.85
Other Financing Activities
---0.16-0.05-0.96-3.23
Financing Cash Flow
0.220.2535.8212.99214.67323.1
Net Cash Flow
0.286.22-26.63-281.97315.947.76
Beginning Cash & Cash Equivalents
23.8172.2498.86380.8464.9417.18
Free Cash Flow
-113.65-90.96-60.14-111.25-97.78-75.66
FCF Margin
-744.28%-457.29%-1018.67%---
Free Cash Flow Per Share
-16.95-13.65-9.33-19.14-17.37-27.76
Levered Free Cash Flow
-101.72-159.34-71.64-138.87-116.4-84.77
Unlevered Free Cash Flow
-108.89-170.07-83.6-143.41-116.35-85.36
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q